Leadership Overview
Catalent has 5 executives leading key functions including revenue generation, financial planning, account management, human resources, and pharmaceutical operations.
Committed to advancing global health outcomes, Catalent optimizes product development and manufacturing for pharmaceutical partners through deep expertise in delivery technologies and multi-modality supply chain solutions.
Committed to advancing global health outcomes, Catalent optimizes product development and manufacturing for pharmaceutical partners through deep expertise in delivery technologies and multi-modality supply chain solutions.
Leadership Roles at Catalent
Christopher Hajjar - Vice President, Finance & Biologics, Corporate Financial Planning & Analysis Segment Chief Financial Officer
Christopher Hajjar, the Vice President, Finance & Biologics, Corporate Financial Planning & Analysis Segment Chief Financial Officer at Catalent, manages fiscal health and strategic resource allocation for the biologics division. Overseeing complex financial modeling, the Vice President, Finance & Biologics, Corporate Financial Planning & Analysis Segment Chief Financial Officer ensures precise budgeting for multi-modality manufacturing projects. This leadership role involves providing critical data insights to the Board to support capital investment decisions in advanced delivery technologies. By streamlining financial reporting processes, Christopher Hajjar directly impacts the efficiency of the global supply chain. Hajjar maintains rigorous oversight of cost structures, ensuring profitability across diverse pharmaceutical product life cycles. Through disciplined financial governance, the Vice President, Finance & Biologics, Corporate Financial Planning & Analysis Segment Chief Financial Officer secures the necessary funding to scale operations, ultimately strengthening the market position of the organization within the competitive pharmaceutical manufacturing landscape.
Aris Gennadios - Group President, Pharma & Consumer Health
Aris Gennadios, the Group President, Pharma & Consumer Health at Catalent, directs the operational execution and strategic growth of the core pharmaceutical and consumer health business units. Overseeing large-scale manufacturing operations, the Group President, Pharma & Consumer Health ensures that development sciences and delivery technologies meet the highest quality standards for global partners. This leadership role involves coordinating with the C-suite to align production capabilities with market demand for personalized medicines and blockbuster drugs. By optimizing manufacturing workflows, Aris Gennadios directly impacts the speed-to-market for critical health products. Gennadios maintains a focus on operational efficiency and technological integration, ensuring the organization remains a leader in the CDMO space. Through rigorous oversight of regional production facilities, the Group President, Pharma & Consumer Health secures the operational scale required to support the diverse needs of the global pharmaceutical industry, driving consistent growth and value for all stakeholders.
Sarah Hauer - Chief Revenue Officer
Sarah Hauer, the Chief Revenue Officer at Catalent, directs global sales strategies to accelerate market penetration for pharmaceutical and biotech partners. Overseeing the commercial pipeline, the Chief Revenue Officer ensures alignment between product development services and client requirements. This leadership role involves expanding market share across North American and European territories through targeted business development initiatives. By optimizing the sales funnel and managing complex contract negotiations, Sarah Hauer directly impacts the company's revenue growth and long-term financial stability. Hauer maintains close collaboration with the executive team to refine pricing models and service offerings, ensuring the organization remains a preferred partner for blockbuster drugs and personalized medicines. Through rigorous analysis of market trends, the Chief Revenue Officer secures competitive advantages, driving sustainable expansion and operational excellence across the entire global portfolio of the organization.
Kassandra Walsh - Senior Account Director & Chief Revenue Officer
Kassandra Walsh, the Senior Account Director & Chief Revenue Officer at Catalent, manages high-value client relationships and drives revenue growth within the consumer health segment. Overseeing strategic account planning, the Senior Account Director & Chief Revenue Officer ensures that brand extensions receive optimal support throughout the development life cycle. This leadership role involves coordinating cross-functional teams to deliver tailored manufacturing solutions that meet specific client needs. By fostering long-term partnerships, Kassandra Walsh directly impacts the retention rates and overall market influence of the company. Walsh maintains a focus on identifying new business opportunities, ensuring the organization remains at the forefront of pharmaceutical innovation. Through proactive engagement with key stakeholders, the Senior Account Director & Chief Revenue Officer secures consistent revenue streams, driving operational success and reinforcing the reputation of the organization as a premier CDMO partner for global health brands.
Lisa Evoli - Senior Vice President and Chief Human Resources Officer
Lisa Evoli, the Senior Vice President and Chief Human Resources Officer at Catalent, architects the global talent strategy to support the complex needs of the pharmaceutical manufacturing workforce. Overseeing organizational development, the Senior Vice President and Chief Human Resources Officer ensures that the company attracts and retains top-tier scientific and operational talent. This leadership role involves designing comprehensive training programs that align with the evolving demands of multi-modality manufacturing. By cultivating a culture of excellence and safety, Lisa Evoli directly impacts the productivity and innovation capacity of the organization. Evoli maintains strategic oversight of compensation and benefits, ensuring competitiveness in the global labor market. Through effective change management and leadership development initiatives, the Senior Vice President and Chief Human Resources Officer secures the human capital necessary to drive the mission of the organization, ensuring that teams remain equipped to deliver life-changing medicines to patients worldwide.
Explore Leadership Teams in Manufacturing
GSK plc is a British multinational pharmaceutical and biotechnology company headquartered in London, United Kingdom. Established in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK is the tenth-largest pharmaceutical company globally. The company discovers, develops, manufactures, and delivers medicines and vaccines with a research and development focus on four primary therapeutic areas: respiratory, immunology and inflammation, oncology, HIV, and infectious diseases. GSK's product portfolio includes specialty medicines, vaccines, and general medicines targeting conditions such as HIV, respiratory diseases, cancer, immuno-inflammation, anti-viral, central nervous system disorders, metabolic conditions, cardiovascular disease, urogenital conditions, anti-bacterial treatments, dermatology, and rare diseases. The company also offers over-the-counter products for pain relief, oral health, nutrition, skin health, and gastrointestinal diseases. GSK has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. In July 2024, the company moved its global headquarters to New Oxford Street in central London, positioning itself within the city's Knowledge Quarter near world-class science and academic institutions including the Francis Crick Institute and King's College London. The new headquarters houses approximately 3,000 employees including the global leadership team and teams supporting research and development, supply chain, commercial operations, and corporate functions. GSK sells its products through wholesalers, pharmacies, hospitals, physicians, and other healthcare groups globally, aiming to positively impact the health of 2.5 billion people by the end of the decade.
Company Leadership LT
PL
RH
Boehringer Ingelheim is a privately held, research-driven pharmaceutical company headquartered in Ingelheim am Rhein, Germany, founded in 1885. The company researches, develops, and manufactures prescription medicines and healthcare products across three core business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Its primary therapeutic focus areas include respiratory diseases, oncology, immunology, cardiometabolic conditions, and central nervous system disorders. Boehringer Ingelheim also develops and manufactures veterinary products for companion animals, livestock, and poultry. Operating in over 100 countries with more than 53,000 employees globally, the company maintains a broad network of research, manufacturing, and commercial sites across Europe, North America, and Asia. It is one of the largest privately owned pharmaceutical companies in the world.
Company Leadership DP
SG
AG
Founded in 1949 and Headquartered in Mumbai, India, Ipca Laboratories Limited (IPCA) is a fully integrated pharmaceutical company manufacturing and marketing over 350 formulations and 80 API's covering various therapeutic segments.
Company Leadership SN
AP
SL
SM
PCI Pharma Services is an integrated full service provider to companies in the global healthcare industry. They offer services including analytical services, formulation development, clinical trial supply, commercial manufacturing and packaging, QP services, supply chain management, storage, and distribution. They are headquartered in Philadelphia, Pennsylvania with locations in the United States and Europe.
Company Leadership
HL
BK
Frequently Asked Questions Regarding Catalent Top Executives and Leadership Team
